VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.

Phase 2

Vanda Pharmaceuticals